Trident Texofab Ltd.

Financial

	Trident Texofab	Raghuvir Synth.	Ashima
Operational Metrics
Financials
5 yr Average ROE	7.91 %	1.08 %	5.0 %
5yr average Equity Multiplier	5.21	3.48	1.42
5yr Average Asset Turnover Ratio	1.2	2.09	0.44
5yr Avg Net Profit Margin	1.25 %	-0.9 %	-15.46 %
Price to Book	10.16	13.55	1.57
P/E	169.44	37.17	0.0
5yr Avg Cash Conversion Cycle	97.54 Days	17.97 Days	9011.17 Days
Inventory Days	40.58 Days	32.06 Days	1528.72 Days
Days Receivable	128.27 Days	7.31 Days	716.94 Days
Days Payable	86.45 Days	40.51 Days	173.38 Days
5yr Average Interest Coverage Ratio	1.47	3.17	6.94
5yr Avg ROCE	12.93 %	7.6 %	3.7 %
5yr Avg Operating Profit Margin	5.9 %	2.1 %	22.32 %
5 yr average Debt to Equity	2.36	0.9	0.22
5yr CAGR Net Profit	3.71 %	75.79 %	41.24 %
5yr Average Return on Assets	1.54 %	1.75 %	3.08 %
Shareholdings
Promoter Holding	32.16 %	74.91 %	73.49 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-32.74 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0